Combigan Shortage Update: What Patients Need to Know in 2026

If you're a glaucoma patient prescribed Combigan (brimonidine tartrate/timolol maleate), you may have heard concerns about availability or had trouble filling your prescription. Here's the current status as of 2026, what it means for you, and the concrete steps you can take.

Current Combigan Shortage Status (2026)

As of 2026, Combigan is NOT listed on the FDA drug shortage database or the American Society of Health-System Pharmacists (ASHP) shortage list. This means there is no declared national shortage of brimonidine/timolol ophthalmic solution.

However, patients and pharmacists across the country still report intermittent stocking issues — particularly for the brand-name Combigan. This is a distribution and inventory problem, not a manufacturing shortage, but the result for patients at the counter is the same: an unfilled prescription.

A Brief History: Combigan's Patent Battles and Generic Entry

Combigan was first FDA-approved in 2007 by Allergan (now AbbVie). For years, Allergan held patents protecting it from generic competition. Generic manufacturers challenged these patents, leading to prolonged legal battles. The U.S. Court of Appeals for the Federal Circuit ultimately ruled some patents invalid, while upholding a key method patent. As a result, the generic version of Combigan didn't reach pharmacy shelves until April 2022.

The arrival of generic brimonidine/timolol dramatically improved overall access — most patients can now find the generic at competitive prices. But the transition also shifted pharmacy inventory away from brand-name Combigan, which now requires special ordering at many locations.

Why Are Some Patients Still Struggling to Find Combigan?

Even without an official shortage, several factors create localized access gaps in 2026:

• Brand vs. generic split: Many pharmacies stock only the generic, not the brand name. Patients whose prescriptions specify "Combigan" (dispense as written) may be turned away even when the generic is available.
• Low stocking volumes: Ophthalmic solutions are specialty items with higher per-unit costs. Pharmacies stock fewer bottles and can run out quickly when multiple patients fill at the same time.
• Insurance routing delays: Some insurance plans require prior authorization before covering Combigan. Approval delays can create gaps in medication access even when the drug itself is available.
• Sterilized manufacturing complexity: Eye drops require sterile manufacturing environments. Any production disruption — even minor — can ripple through the supply chain and temporarily reduce availability in certain regions.

What Should Patients Do Right Now?

If you're having trouble filling your Combigan prescription, here are your best options:

1. Accept the generic: Ask your doctor to authorize generic brimonidine tartrate/timolol maleate. It's FDA-approved as therapeutically equivalent and much easier to find.
2. Use medfinder: medfinder calls pharmacies near you to check which ones have Combigan in stock and texts you the results. This saves hours of calling around on your own.
3. Call your ophthalmologist immediately: Explain the situation. They may have samples, know which local pharmacies stock Combigan, or provide a bridge prescription for an alternative like Cosopt or Simbrinza.
4. Try mail order: Many insurance plan mail-order pharmacies maintain larger inventories than retail locations. This option works best when you have a few days of medication left and aren't in an emergency.

37,797+ patients found their medications in stock

37K+

Find Combigan In Stock Today →

Why Vision Protection Cannot Wait

Combigan is prescribed precisely because other medications weren't controlling IOP well enough on their own. That means if you're on Combigan, your glaucoma may be more advanced or harder to control than average. Even a short gap in treatment — a few days — can allow dangerous pressure spikes. Optic nerve damage from glaucoma is permanent and cannot be reversed.

Don't wait to see if Combigan turns up at your regular pharmacy. Take action on the day you realize you can't fill your prescription.

The Bottom Line for 2026

There is no declared shortage of Combigan in 2026. The medication is being manufactured and distributed. But pharmacy availability is inconsistent — especially for the brand-name version. The most reliable solutions are accepting the generic substitution, checking multiple pharmacies, and using tools like medfinder to find stock faster. For a full walkthrough, see our guide on how to find Combigan in stock near you.